Cancer statistics, 2024

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2020) and mortality data collecte...

Full description

Saved in:
Bibliographic Details
Published in:CA: a cancer journal for clinicians 2024-01, Vol.74 (1), p.12-49
Main Authors: Siegel, Rebecca L., Giaquinto, Angela N., Jemal, Ahmedin
Format: Article
Language:English
Subjects:
Cancer
cancer cases
cancer statistics
Cervix
Colorectal carcinoma
death rates
Female
Human papillomavirus
Humans
Incidence
Kidneys
Liver
Male
Melanoma
Metastases
Minority & ethnic groups
Mortality
Neoplasms - epidemiology
Neoplasms - therapy
Prostate
Registries
Smoking
Statistics
United States - epidemiology
Uterus
White
Young Adult
Young adults
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2020) and mortality data collected by the National Center for Health Statistics (through 2021). In 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both the adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers. Incidence rates increased during 2015–2019 by 0.6%–1% annually for breast, pancreas, and uterine corpus cancers and by 2%–3% annually for prostate, liver (female), kidney, and human papillomavirus‐associated oral cancers and for melanoma. Incidence rates also increased by 1%–2% annually for cervical (ages 30–44 years) and colorectal cancers (ages
ISSN:0007-9235
1542-4863
DOI:10.3322/caac.21820